Interaction between intravenous immunoglobulin (IVIg) and the low-density lipoprotein receptor-related protein 1: A role for transcytosis across the blood brain barrier?

• Published in: Journal of neuroimmunology 2012-10, Vol.251 (1), p.39-44
• Main Authors: Proulx, Dominic Paquin, Rouleau, Pascal, Paré, Isabelle, Vallières-Noël, Marie-Michelle, Bazin, Renée
• Format: Article
• Language: English
• Subjects: Allergy and Immunology; Animals; Biological Transport - physiology; Blood-Brain Barrier - metabolism; Cell Line; Endocytosis; Immunoglobulins, Intravenous - metabolism; Intravenous immunoglobulin; IVIg; LRP1; Mice; Neurology; Phosphorylation - physiology; Receptors, LDL - metabolism; Transcytosis; Tumor Suppressor Proteins - metabolism; Tyrosine - metabolism
• ISSN: 0165-5728; 1872-8421
• DOI: 10.1016/j.jneuroim.2012.06.009

Abstract Intravenous immunoglobulin (IVIg) is a therapeutic preparation of plasma-derived human IgG and is increasingly used for the treatment of several neurological inflammatory disorders. However, it is not clear whether the IgG molecules contained in IVIg can actually cross the BBB in treated patients. We recently showed that LRP1, an endocytic receptor involved in transcytosis of several proteins across the BBB was able to interact with IVIg. In the present study, we show that LRP1 is involved in IVIg internalization inside living cells. Our data also suggest that following internalization, IVIg is recycled to the cell surface, raising the possibility that LRP1 can mediate IVIg transcytosis across the BBB. Finally, we show that IVIg–LRP1 interaction leads to LRP1 tyrosine phosphorylation.